Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A G Protein-Biased Ligand at theμ-Opioid Receptor Is Potently Analgesic with Reduced Gastrointestinal and Respiratory Dysfunction Compared with Morphine
Scott M. DeWire, Dennis S. Yamashita, David H. Rominger, et al.
Journal of Pharmacology and Experimental Therapeutics (2013) Vol. 344, Iss. 3, pp. 708-717
Closed Access | Times Cited: 555

Showing 26-50 of 555 citing articles:

GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures
Ichio Shimada, Takumi Ueda, Yutaka Kofuku, et al.
Nature Reviews Drug Discovery (2018) Vol. 18, Iss. 1, pp. 59-82
Open Access | Times Cited: 217
Intracranial Self-Stimulation to Evaluate Abuse Potential of Drugs
S. Stevens Negus, Laurence L. Miller
Pharmacological Reviews (2014) Vol. 66, Iss. 3, pp. 869-917
Open Access | Times Cited: 211
New Insights into Modes of GPCR Activation
Wenjing Wang, Yuhui Qiao, Zijian Li
Trends in Pharmacological Sciences (2018) Vol. 39, Iss. 4, pp. 367-386
Closed Access | Times Cited: 201
Cannabinoid CB1and CB2Receptor Signaling and Bias
Mikkel Søes Ibsen, Mark Connor, Michelle Glass
Cannabis and Cannabinoid Research (2017) Vol. 2, Iss. 1, pp. 48-60
Open Access | Times Cited: 194
Conformational Basis of G Protein-Coupled Receptor Signaling Versatility
Laura M. Wingler, Robert J. Lefkowitz
Trends in Cell Biology (2020) Vol. 30, Iss. 9, pp. 736-747
Open Access | Times Cited: 192
A randomized, phase 2 study investigating TRV130, a biased ligand of the μ-opioid receptor, for the intravenous treatment of acute pain
Eugene R. Viscusi, Lynn R. Webster, Michael E. Kuss, et al.
Pain (2015) Vol. 157, Iss. 1, pp. 264-272
Closed Access | Times Cited: 185
Fulfilling the Promise of "Biased" G Protein–Coupled Receptor Agonism
Louis M. Luttrell, Stuart Maudsley, Laura Bohn
Molecular Pharmacology (2015) Vol. 88, Iss. 3, pp. 579-588
Open Access | Times Cited: 180
Improving translation of animal models of addiction and relapse by reverse translation
Marco Vènniro, Matthew L. Banks, Markus Heilig, et al.
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 11, pp. 625-643
Closed Access | Times Cited: 176
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 202-277
Open Access | Times Cited: 156
Molecular recognition of morphine and fentanyl by the human μ-opioid receptor
Youwen Zhuang, Yue Wang, Bingqing He, et al.
Cell (2022) Vol. 185, Iss. 23, pp. 4361-4375.e19
Open Access | Times Cited: 149
Opioid Analgesia and Opioid-Induced Adverse Effects: A Review
Alok Kumar Paul, Craig M. Smith, Mohammed Rahmatullah, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 11, pp. 1091-1091
Open Access | Times Cited: 142
G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Mingyang Zhang, Ting Chen, Xun Lu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 94
Insights into distinct signaling profiles of the µOR activated by diverse agonists
Qianhui Qu, Weijiao Huang, Deniz Aydin, et al.
Nature Chemical Biology (2022) Vol. 19, Iss. 4, pp. 423-430
Open Access | Times Cited: 83
Structure-based design of bitopic ligands for the µ-opioid receptor
Abdelfattah Faouzi, Haoqing Wang, Saheem A. Zaidi, et al.
Nature (2022) Vol. 613, Iss. 7945, pp. 767-774
Closed Access | Times Cited: 81
Molecular mechanism of biased signaling at the kappa opioid receptor
Amal El Daibani, Joseph M. Paggi, Kuglae Kim, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 58
β−Arrestins: Structure, Function, Physiology, and Pharmacological Perspectives
Jürgen Wess, Antwi‐Boasiako Oteng, Osvaldo Rivera‐Gonzalez, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 854-884
Open Access | Times Cited: 51
An Overview of Recent Developments in the Management of Burn Injuries
Elżbieta Radzikowska-Büchner, Inga Łopuszyńska, Wojciech Flieger, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16357-16357
Open Access | Times Cited: 44
Ligand efficacy modulates conformational dynamics of the µ-opioid receptor
Jiawei Zhao, Matthias Elgeti, Evan S. O’Brien, et al.
Nature (2024) Vol. 629, Iss. 8011, pp. 474-480
Open Access | Times Cited: 17
Profiling the proximal proteome of the activated μ-opioid receptor
Benjamin J. Polacco, Braden T. Lobingier, Emily E. Blythe, et al.
Nature Chemical Biology (2024) Vol. 20, Iss. 9, pp. 1133-1143
Closed Access | Times Cited: 16
Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery
Paolo Conflitti, Edward Lyman, Mark S.P. Sansom, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 1
The G Protein–Biased κ-Opioid Receptor Agonist RB-64 Is Analgesic with a Unique Spectrum of Activities In Vivo
Kate L. White, J. Elliott Robinson, Hu Zhu, et al.
Journal of Pharmacology and Experimental Therapeutics (2014) Vol. 352, Iss. 1, pp. 98-109
Open Access | Times Cited: 185
Structure–Activity Relationships and Discovery of a G Protein Biased μ Opioid Receptor Ligand, [(3-Methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro-[4.5]decan-9-yl]ethyl})amine (TRV130), for the Treatment of Acute Severe Pain
Xiaotao Chen, Philip Pitis, Guodong Liu, et al.
Journal of Medicinal Chemistry (2013) Vol. 56, Iss. 20, pp. 8019-8031
Closed Access | Times Cited: 174
Targeting multiple opioid receptors – improved analgesics with reduced side effects?
Thomas Günther, Pooja Dasgupta, Anika Mann, et al.
British Journal of Pharmacology (2017) Vol. 175, Iss. 14, pp. 2857-2868
Open Access | Times Cited: 155
Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs
John D. McCorvy, Kyle V. Butler, Brendan Kelly, et al.
Nature Chemical Biology (2017) Vol. 14, Iss. 2, pp. 126-134
Open Access | Times Cited: 154
Advances in Achieving Opioid Analgesia Without Side Effects
Halina Machelska, Melih Ö. Celik
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 153

Scroll to top